Literature DB >> 26398693

VITREORETINAL COMPLICATIONS IN EYES WITH BOSTON KERATOPROSTHESIS TYPE I.

Pukhraj Rishi1, Ekta Rishi, Vikram V Koundanya, Gaurav Mathur, Geetha Iyer, Bhaskar Srinivasan.   

Abstract

PURPOSE: To describe the spectrum of vitreoretinal complications in eyes with Boston keratoprosthesis type I and evaluate the treatment outcomes.
METHODS: This was a retrospective interventional case series of 23 of 45 eyes that underwent Boston keratoprosthesis from April 2003 to December 2013 and developed vitreoretinal complications. Types of vitreoretinal complications, surgical techniques, and anatomical and visual outcomes were analyzed.
RESULTS: Vitreoretinal complications in eyes with Boston keratoprosthesis included retroprosthetic membranes (n = 11), retinal detachment (n = 6), endophthalmitis (n = 4), epiretinal membrane (n = 4), vitreous hemorrhage (n = 2), and choroidal detachment (n = 1). Twenty of 23 eyes (87%) underwent surgical intervention. Retinal reattachment was achieved in 5 eyes (83%) with significant visual improvement in 3 (50%). Mean preoperative visual acuity improved from 1.84 ± 0.89 logMAR to 1.5 ± 0.87 logMAR (P = 0.01) at the last follow-up. Mean 1.4 surgical procedures were performed per eye. Mean follow-up was 28 months (median: 28 months, range: 5-57 months).
CONCLUSION: Retroprosthetic membrane and retinal detachment are most common vitreoretinal complications in eyes with Boston keratoprosthesis. Vitreoretinal complications can be managed by appropriate intervention in such eyes with encouraging anatomical and functional results.

Entities:  

Mesh:

Year:  2016        PMID: 26398693     DOI: 10.1097/IAE.0000000000000740

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

1.  Wide-field vitreoretinal surgery in eyes with Boston type 1 keratoprosthesis.

Authors:  Canan Asli Utine; Mahmut Kaya; Kıvanç Kasal
Journal:  Int Ophthalmol       Date:  2021-10-12       Impact factor: 2.031

2.  COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY.

Authors:  Jennifer I Lim; Lindsay Machen; Andrea Arteaga; Faris I Karas; Robert Hyde; Dingcai Cao; Marcia Niec; Thasarat S Vajaranant; M Soledad Cortina
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

3.  Risk of Endophthalmitis in Boston Type 1 Keratoprosthesis Combined with Vitrectomy and Silicone Oil Insertion.

Authors:  Mohamed Abou Shousha; Taher Eleiwa; Allister Gibbons; Christopher Smith; Sean Edelstein; George Kontadakis; Zachary Schmitz; Joshua Abernathy; Ross Chod; Zachary Bodnar; Kelvin McDaniel; Rocio Bentivegna; Levent Akduman
Journal:  J Ophthalmol       Date:  2019-07-25       Impact factor: 1.909

Review 4.  Boston Type 1 Keratoprosthesis: Updated Perspectives.

Authors:  Manachai Nonpassopon; Muanploy Niparugs; Maria Soledad Cortina
Journal:  Clin Ophthalmol       Date:  2020-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.